Skip to search.
 FTSE 100 Up 3.08%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM
5.33 Up 0.09(1.72%) 12 Feb 21:00
Prev Close:5.24
Open:5.37
Bid:4.50 x 200
Ask:N/A
1y Target Est:14.00
Beta:0.985818
Earnings Date:1 Mar - 7 Mar (Est.)
Day's Range:4.99 - 5.48
52wk Range:4.99 - 18.83
Volume:2,445,844
Avg Vol (3m):2,011,530
Market Cap:666.39m
P/E (ttm):N/A
EPS (ttm):-1.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for FOLD at this time.

Comparison

Symbol% ChgMkt Cap
FOLDUp 1.72%666.39m

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.15
Quarterly EPS Est (Dec-15) :-0.31
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amicus Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapeutic products for rare and orphan diseases. Its product candidate is a small molecule that can be used as a monotherapy and in combination with enzyme repla... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback